<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d19" origId="Etidronic acid"><sentence id="DrugDDI.d19.s0" origId="s0" text="There have been isolated reports of patients experiencing increases in their prothrombin times when etidronate was added to warfarin therapy."><entity id="DrugDDI.d19.s0.e0" origId="s0.p10" charOffset="100-110" type="drug" text="etidronate"/><entity id="DrugDDI.d19.s0.e1" origId="s0.p13" charOffset="124-132" type="drug" text="warfarin"/><pair id="DrugDDI.d19.s0.p0" e1="DrugDDI.d19.s0.e0" e2="DrugDDI.d19.s0.e1" interaction="true"/></sentence><sentence id="DrugDDI.d19.s1" origId="s1" text="The majority of these reports concerned variable elevations in prothrombin times without clinically significant sequelae."/><sentence id="DrugDDI.d19.s2" origId="s2" text="Although the relevance of these reports and any mechanism of coagulation alterations is unclear, patients on warfarin should have their prothrombin time monitored."><entity id="DrugDDI.d19.s2.e0" origId="s2.p28" charOffset="109-117" type="drug" text="warfarin"/></sentence></document>